A Mobile Brain/Body Imaging Platform for the Assessment and Optimization of Post-stroke Overground Robotic Gait Treatments
Dr. Franco Molteni
30 participants
May 6, 2025
INTERVENTIONAL
Conditions
Summary
The study aims to identify neural biomarkers that can be used to monitor the recovery of locomotion and movement of post-stroke patients, both in natural settings and with enriched treatment using robotic device. These biomarkers could potentially be utilized in clinical practice to improve recovery outcomes. Additionally, the study seeks to investigate whether it is feasible to use these biomarkers to predict the extent of recovery that patients may achieve.
Eligibility
Inclusion Criteria10
- Age ≥18 years old
- Stroke patients with different etiology: ischemic or hemorrhagic
- Able to walk independently, eventually with aids/orthosis (FAC\>2)
- Able to give the informed consent and to comprehend the instructions necessary to complete the task
- Subject's anthropometric parameters adequate to wear the exoskeleton;
- Body weight \< 90 kg;
- Height 150 ÷ 192 cm;
- Thigh lenght: 355 ÷ 475 mm;
- Calf lenght: 405 ÷ 485 mm;
- Hip width : 690 ÷ 990 mm;
Exclusion Criteria4
- Incapacity to give the informed consent and understand the tasks required
- Fixed contracture at lower limbs that limits the use of the exoskeleton
- Incapacity to walk independently (FAC\<=2)
- Subject's anthropometric parameters not adequate to wear the exoskeleton
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
To provide a complete overview of the complex system patient-technology, motor and cognitive evaluations, commonly used in daily clinical practice, will be performed at pre-treatment time (T0), after 12 sessions of treatment (T1) and one month follow-up time (T2). The first (E1) and the last session (E12) of treatment will be instrumented with EEG, EMG and GRF which will collect data.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07510633